Omzar (Esomeprazole Magnesium Dihydrate)

Esomeprazole selectively and irreversibly inhibits the gastric H+/K+‑ATPase (proton pump) on parietal cells, blocking the final step of acid secretion. This suppression of gastric acid creates a less acidic environment, which alleviates symptoms and allows damaged mucosa to heal.

The specific dose of Omzar is determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Healthcare professionals set the appropriate strength and dosing schedule according to current clinical guidelines.

Omzar should be used in pregnancy or while breastfeeding only when clearly needed and after a careful risk‑benefit assessment by the prescriber. Limited data suggest it is generally considered low risk, but clinicians should evaluate individual circumstances before prescribing.

To order Omzar, submit an enquiry on the product page at gnhindia.com, providing the required quantity and your institutional details. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before responding with pricing, availability, shipping terms and any necessary import documentation.

Omzar (esomeprazole) is the S‑enantiomer of omeprazole, offering more consistent acid suppression and a slightly longer duration of action compared with racemic PPIs. Clinical efficacy is comparable to other PPIs, but some patients may experience better symptom control or fewer drug‑interaction concerns with esomeprazole.

Omzar tablets should be stored at ambient temperature, below 25 °C, in their original packaging. Protect the product from moisture and direct sunlight to maintain stability throughout its shelf life.

Omzar is taken orally, usually as a whole tablet with water. It can be taken with or without food, but consistent timing each day helps maintain steady acid control. Patients should follow the prescriber’s instructions regarding timing relative to meals.

Serious risks, though uncommon, include severe allergic reactions, Clostridioides difficile‑associated diarrhea, low magnesium levels, increased fracture risk with long‑term use, and rare cases of liver enzyme elevation or acute interstitial nephritis. Patients should report any unusual symptoms promptly.

Omzar is contraindicated in individuals with known hypersensitivity to esomeprazole, other PPIs, or any component of the formulation. Caution is also advised for patients with severe liver disease, those taking interacting medications such as clopidogrel, and patients with a history of fractures or low magnesium levels.